Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × palbociclib × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 40 Lymphoid 10 Gastrointestinal 8 Other hematologic neoplasm 6 Thoracic 5 Gynecologic 5 Tumor-Agnostic 3 Sarcoma 3 Other solid neoplasm 3 Head & Neck 3 Genitourinary 3 Plasma cell 2 Dermatologic 2 CNS 2 Other neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Breast Cancer Metastatic 1

Interventions

Biopsy 4 Cyclophosphamide 3 Microarray Analysis 2 Methylprednisolone 2 Filgrastim 2 Colposcopy 2 Carboplatin 2 toripalimab 1 tipifarnib 1 sargramostim 1 sapanisertib 1 pyroxamide 1 pirfenidone 1 penpulimab 1 palbociclib 1 liposomal doxorubicin 1 iodixanol 1 human papillomavirus vaccine, TA 1 artemisinin 1 arginine butyrate 1 Zoledronic Acid 1 Vincristine 1 Video-Assisted Surgery 1 Topotecan 1 Tetradecanoylphorbol Acetate 1 Taxes 1 Tacrolimus 1 Specimen Handling 1 Sorafenib 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡